In a laboratory working with peptides, there comes a moment when the supplier sends a certificate of analysis with two key data: an HPLC chromatogram with the declaration “purity ≥98%” and a mass spectrum with the molecular mass consistent with the theoretical value. To a person without a background in analytical chemistry, both documents look like a technical formality – a strip of peaks, a few numbers, the signature of a QC employee. For the research team planning an experiment, the values of these two documents are the foundation for everything that happens next. Without them, the peptide is simply a white powder of unknown identity and purity.
High performance liquid chromatography (HPLC) and mass spectrometry (MS) are two basic analytical techniques used in research peptidology. They both answer different questions. Both are essential. Understanding, what exactly does each technique verify? – and which none of them verifies on their own – is the first element of the scientific workshop when working with peptides. You can find more context on quality standards and supplier ratings in the overview article how to recognize high-quality research peptides.
This article compares both methods from the perspective of a researcher receiving a peptide from a supplier: what to read in the chromatogram, what to read in the mass spectrum, how to interpret the results together, and when additional analytical techniques are needed.
📖 The following article is educational and describes the principles of research peptide analysis in the context of assessing the quality of reagents (Research Use Only). It does not constitute technical advice on specific laboratory protocols – consult your peptide supplier’s QC team for advanced analyses.
What is HPLC – the foundation of purity determination
High performance liquid chromatography (High-Performance Liquid Chromatography, HPLC) is a separation technique in which a mixture of substances dissolved in the liquid phase passes through a column filled with a sorbent. Different substances are retained in the column with different forces – as a result, they leave the column at different times. The detector records the flow of individual fractions, generating chromatogram.
It is standard in peptology Reverse phase HPLC (Reversed-Phase HPLC, RP-HPLC).
Mechanism of reversed phase separation
In RP-HPLC, the chromatographic column is filled with a hydrophobic sorbent – most often silica gel modified with 18-carbon aliphatic chains (column C18). The mobile phase is a mixture of:
- Water with added modifier (usually 0.1% trifluoroacetic acid – TFA – as ion pair)
- Acetonitrile or methanol as an organic modifier
The peptide passes through the column at a speed that depends on its hydrophobicity:
- More hydrophobic peptides (with aromatic residues: phenylalanine, tryptophan, tyrosine; or aliphatic residues: leucine, isoleucine, valine) – interact more strongly with C18, retained in the column longer
- More hydrophilic peptides (with polar residues: glutamic acid, lysine, arginine, serine) – interact less strongly with C18, leave the column faster
This time separation allows the target peptide to be separated from related contaminants:
- Peptides with missing amino acids (deletion peptides from SPPS synthesis)
- Peptides with added amino acids (insertion peptides)
- Stereoisomers (D vs L amino acids)
- Hydrolytic fragments (resulting from degradation)
- Peptides with incomplete modifications (e.g. unactivated protecting groups)
What the detector records – UV at 220 nm
The standard HPLC detector for peptides is a UV detector set at wavelength 220nm — corresponding to the absorption of peptide bonds. Each peptide bond (—CO—NH—) absorbs UV light at this wavelength, so the signal is proportional to the number of peptide bonds in the molecule.
In practice: a peptide with 30 amino acids (29 peptide bonds) generates a stronger signal than a peptide with 7 amino acids (6 bonds) at the same molar concentration. Therefore, for purity comparisons, one should operate on peak area ratios within one chromatogram, not absolute signal heights.
Some laboratories use a diode detector (PDA) at a wide range of wavelengths – this additionally provides information about the absorption spectrum of each peak, useful for identification.
How to read a chromatogram
A typical chromatogram of a research peptide shows:
Signal │
│ ┃
│ ┃ main peak
│ ┃
│ ┃
│ ┃
│ │ ┃ │
│__|__│______┃________│___
t=retention time
- Main peak — the highest, the widest. Corresponds to the target molecule.
- Associated peaks — minor, close to the main peak or in other positions. They represent pollutants.
- Baseline — detector signal without analyte. It should be stable.
Peptide purity is calculated as the ratio of the area under the main peak to the sum of the areas under all peaks in the chromatogram. Industry standard in research peptidology: ≥98%.
Features of a good vs poor chromatogram
| Characteristic | Good chromatogram | Poor chromatogram |
|---|---|---|
| Main peak | Sharp, symmetrical, well separated | Wide, asymmetrical, “tapered” |
| Baseline | Low, stable | Hesitant, drifting |
| Associated peaks | Small and few (<1% of the field each) | Multiple or large (>2%) |
| Retention time | Reproducible from batch to batch | Incoherent, “wandering” |
| Resolution | All peaks well separated | Peaks overlap |
What HPLC does not verify
HPLC measures relative purity — what percentage of the recorded signal is the target peptide. It doesn’t answer three important questions:
- Is the recorded peak actually a peptide with the declared sequence? (This is verified by MS)
- How much peptide is in the vial as a mass? (This is verified by peptide content analysis)
- Does the peptide contain no endotoxins or microorganisms? (This is verified by microbiological tests)
Therefore, “HPLC ≥98%” is the first, but not the only, quality assessment element. The full QC suite includes several parallel techniques.
What is mass spectrometry – identity verification
Mass Spectrometry (Mass Spectrometry, MS) is a technique that ionizes molecules and separates the resulting ions according to mass to load ratio (m/z) and records their presence as a mass spectrum. Unlike HPLC—which separates molecules over time—MS separates ions in space or time according to their electromagnetic properties.
In peptidology, MS answers the question: whether this molecule we have in the vial is what we say it is.
Ionization techniques in peptidology
Two dominant techniques:
ESI-MS (Electrospray Ionization)
In ESI, a peptide in solution is sprayed by an electrostatically charged needle. Tiny droplets are formed which lose the solvent, generating multiply charged ions [M+nH]ⁿ⁺.
ESI Features:
- Mild ionization – the peptide does not fragment during the process
- Gives multiply charged ions (a peptide of mass 5000 Da can give the peaks [M+3H]³⁺, [M+4H]⁴⁺, [M+5H]⁵⁺)
- Easily combined with HPLC in LC-MS systems
- The standard for modern proteomics and peptide analysis
MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization – Time of Flight)
In MALDI, the peptide is mixed with a matrix (e.g. CHCA – α-cyano-4-hydroxycinnamic acid), dried on a plate and ionized by a short laser pulse. They are mainly created single-charge ions [M+H]⁺.
MALDI-TOF Features:
- Very fast analysis (seconds)
- It produces mainly single-charge ions
- Good for analysis of solid samples (e.g. lyophilisates)
- Less accurate than high-resolution ESI-MS
It is standard in research peptidology ESI-MS — often combined with HPLC in LC-MS systems.
What does the mass spectrum verify?
The full MS report confirms:
- The molecular mass is consistent with the theoretical one — accuracy of 0.01% in modern spectrometers
- Isotope distribution consistent with theoretical — a peptide is a molecule with a complex isotopic profile (various combinations of ¹²C/¹³C, ¹⁴N/¹⁵N) that must match that expected for a given sequence
- No major contaminants of detectable mass — e.g. peptides with missing amino acid residues (deletions)
MS/MS – full sequence verification
For peptides with unusual modifications or in case of doubt, they are used tandem MS (MS/MS). In this approach:
- The first spectrometer selects a precursor ion (peptide of a specific mass)
- The precursor ion is fragmented in the collision chamber
- The second spectrometer records the fragments
Peptide fragmentation generates characteristic ions type b and y (two types of peptide bond cleavage fragments). From the analysis of the fragment spectrum it can be reconstructed complete amino acid sequence peptide – not just molecular mass.
In standard QC of research peptides, MS/MS is used selectively – only when the primary MS result is questionable or for peptides of particular complexity (post-translational modifications, disulfide bridges).
Which MS doesn’t verify
MS itself does not protect against:
- A peptide of the correct mass but contaminated with fragments of the same nominal mass (rare, but possible)
- Low concentrations of pollutants (MS sensitivity is high but not infinite)
- Non-ionizing impurities under analysis conditions
Therefore, MS alone is not enough – you need an HPLC that measures the signal ratio.
HPLC + MS – complementarity of techniques
The simplest and most common combination in peptidology is HPLC + MS used together:
| Characteristic | HPLC | MS |
|---|---|---|
| Question | How pure is the peptide? | What is the identity of the peptide? |
| What it measures | Relative purity in the signal | Molecular mass and isotopic distribution |
| Strong point | Quantitative purity assessment | Specific molecular identification |
| Weak side | It does not identify the molecule | It does not quantify the proportion of impurities |
| Complementarity | “98% of the signal is the same molecule” | “This particle has a mass consistent with the declaration” |
Together they give a qualitative picture: the peptide is both pure and correctly identified. One of the techniques without the other leaves gaps in interpretation.
LC-MS – integrated system
In advanced analytical laboratories, HPLC and MS are often integrated into one system LC-MS — liquid chromatography with mass detector. In this arrangement:
- The peptide is separated chromatographically on a column (as in classic HPLC)
- Each peak in the chromatogram is immediately analyzed by the mass spectrometer
- Result: chromatogram with additional information about the molecular weight of each peak
LC-MS can identify not only the target peptide, but also specific impurities (e.g. “this peak with a retention time of 8.3 min has a mass of 1352 Da, which is probably a peptide with a missing leucine”).
Other analytical techniques – addition to the QC package
Full assessment of the quality of a research peptide also includes techniques beyond HPLC and MS:
Karl Fischer – humidity
Most peptides are supplied in the form of a lyophilisate. Residual humidity affects stability, dosage and microbiology. Standard: ≤5% humidity (Karl Fischer titration).
LAL – endotoxin test
Endotoxins (lipopolysaccharides of Gram-negative bacteria) induce a strong inflammatory response when administered in vivo. The LAL (Limulus Amebocyte Lysate) test measures the presence of endotoxins with high sensitivity. Standard for injectable peptides: ≤1 EU/mg.
Amino acid analysis – peptide content
Peptide content is the percentage of peptide in the lyophilized product (takes into account residual water, salts, counterions, possible non-peptide impurities). Classic method: peptide hydrolysis and quantitative amino acid analysis. Modern methods use HPLC with internal standards.
Sterility test
For peptides used in in vivo injection models, a standard consistent with the pharmacopoeia (USP <71> or Ph.Eur. 2.6.1).
ICP-MS – Copper Analysis (for GHK-Cu and similar)
For peptides complexing with metals (GHK-Cu) is standard inductively coupled plasma mass spectrometry (ICP-MS) – measures copper content in a 1:1 stoichiometric ratio to the peptide.
Practical conclusions for researchers
What to verify in the COA received from the supplier
A professional certificate of research peptide analysis should include:
- HPLC chromatogram with attached declaration of purity (≥98%)
- MS spectrum (or text report) with the molecular weight consistent with the theoretical one
- Report by Karl Fischer with humidity (≤5%)
- LAL test for injectable peptides (≤1 EU/mg)
- Lot number associated with the vial
- Date of synthesis and expiration date
- QC employee’s signature
The absence of any of the elements is a warning signal. Detailed supplier evaluation criteria and red flags are discussed in the overview article on analytical and purchasing standards.
Red flags in certificates of analysis
| Signal | What could it mean? |
|---|---|
| Generic “benchmark” COA for all lots | No actual batch analysis |
| No HPLC chromatogram, only the declaration “≥98%” | Unverified cleanliness |
| No MS spectrum, only mass declaration | Unverified identity |
| Lot number on the vial ≠ number in the COA | Mistake or forgery |
| Declared purity >100% | Miscalculation (mathematical impossibility) |
| No signature of the QC employee | Doubtful authenticity |
FAQ – Frequently asked questions
Does “HPLC ≥98%” mean that the peptide is what it claims?
NO. HPLC only measures relative purity – what percentage of the signal in the chromatogram is the same molecule. It doesn’t identify what molecule it is. Identity is verified by mass spectrometry (MS). Full QC always includes both techniques.
Why is the research peptide 98% pure and not 100% pure?
Peptide synthesis (mainly SPPS – solid-phase peptide synthesis) always generates small amounts of by-products: peptides with missing amino acids (deletions), with incomplete modifications, hydrolytic fragments. Chromatographic purification reduces these impurities, but 100% purity is virtually impossible to achieve. The 98% standard is the optimal compromise between quality and production costs.
How does ESI-MS differ from MALDI-TOF?
ESI-MS ionizes the peptide in solution by electrostatic sputtering – producing multiply charged ions, easily combined with HPLC. MALDI-TOF ionizes the peptide on the plate surface with a laser pulse – it produces mainly single-charge ions, faster but less accurate. ESI-MS is the standard in modern peptidology.
What does peptide content analysis verify?
Percentage of peptide in the lyophilisate. The lyophilisate is not pure peptide – it additionally contains residual water, buffer salts and counterions. Peptide content (usually 70-90%) tells how much peptide there is actually in a gram of lyophilisate. Helpful for precise dosing in experiments.
Is MALDI-TOF better than ESI-MS for peptides?
There is no clear answer – it depends on the context. MALDI-TOF is faster and simpler, good for the analysis of solid samples. ESI-MS is more accurate, easier to combine with HPLC, and provides more structural information. ESI-MS dominates in research peptology (especially in LC-MS systems), MALDI-TOF is used in specific applications (e.g. identity analysis in standard QC).
What does “resolution” mean in MS?
Resolution is the ability of a spectrometer to separate two ions with very close masses. Modern high-resolution spectrometers (Orbitrap, FT-ICR) can distinguish ions that differ by single daltons, even in the range of several thousand Da. This allows you to distinguish the actual peptide from impurities with almost identical nominal mass.
Is the LAL test required for all peptides?
By default, yes – for peptides used in in vivo injection models (animal or cellular). Endotoxins in the peptide can bias experimental results by activating TLR4 and triggering an inflammatory response. For peptides used solely in chemical analysis (without contact with living cells), LAL is less critical.
How to interpret “molecular mass identity” in COA?
In standard MS, monoisotopic mass (lightest isotopologue) or average molecular mass is reported for research peptides. The result should agree with the theoretical value calculated from the amino acid sequence with an accuracy of ≤0.1% (typically 0.01% in modern spectrometers). Larger deviations suggest an identity or modification problem.
Related content in the knowledge base
- What to pay attention to when buying research peptides
- Peptides and the law in the European Union – legal status of research reagents
- How to recognize high-quality research peptides
- How to Dissolve Peptides – Step by Step Guide
- Laboratory practice with research peptides
- quality & safety category
Full QC documentation of peptides from the One Peptides catalog – HPLC chromatogram, MS spectrum, Karl Fischer report, LAL test – available on the website quality tests and certificates.
Bibliography
- Hancock, W. S., Sparrow, J. T. (1981). Use of mixed-mode, high-performance liquid chromatography for the separation of peptide and protein mixtures
- Aebersold R, Mann M (2003). Mass spectrometry-based proteomics
- Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989). Electrospray ionization for mass spectrometry of large biomolecules
- Karas M, Hillenkamp F (1988). Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons
- Roepstorff P, Fohlman J (1984). Proposal for a common nomenclature for sequence ions in mass spectra of peptides
- Mant CT, Hodges RS (2007). HPLC analysis and purification of peptides
- Domon B, Aebersold R (2006). Mass spectrometry and protein analysis
- Mann M, Wilm M (1995). Electrospray mass spectrometry for protein characterization
- United States Pharmacopeia (2024). USP general chapter <1226> Verification of compendial procedures
ℹ️ Global disclaimer
All One-Peptides products are reagents intended exclusively for laboratory and scientific research (Research Use Only). They are not medicines, dietary supplements or products intended for human consumption. The information in this article is educational in nature and describes analytical techniques used in research peptidology; does not constitute medical, pharmaceutical or technical advice regarding specific laboratory protocols.
Pharmaceutical review: MPharm Aneta Kropicka
Pharmaceutical Reviewer & Sports Supplementation Expert
Master of Pharmacy with 12 years of professional experience, graduate of the Medical University of Lodz (2014). Reviews One Peptides content for pharmacology, clinical dosing, and regulatory compliance across RUO / dietary supplement / drug frameworks.
Published: • Last updated:


